Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$137.20 USD
-3.90 (-2.76%)
Updated May 3, 2024 04:00 PM ET
After-Market: $137.11 -0.09 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
09/03/2024
Time: -- |
6/2024 | $-1.37 | -2.56% |
Earnings Summary
For their last quarter, Ascendis Pharma (ASND) reported earnings of -$2.48 per share, missing the Zacks Consensus Estimate of -$1.57 per share. This reflects a negative earnings surprise of 57.96%. Look out for ASND's next earnings release expected on September 03, 2024. For the next earning release, we expect the company to report earnings of -$1.37 per share, reflecting a year-over-year increase of 41.7%.
Earnings History
Price & Consensus
Zacks News for ASND
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
ASND: What are Zacks experts saying now?
Zacks Private Portfolio Services